Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022

SELL
$4.35 - $15.85 $73,950 - $269,450
-17,000 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$4.55 - $6.41 $31,850 - $44,870
7,000 Added 70.0%
17,000 $82,000
Q4 2021

Feb 15, 2022

BUY
$5.89 - $9.73 $58,900 - $97,300
10,000 New
10,000 $59,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $46.5M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Josh Arnold Investment Consultant, LLC Portfolio

Follow Josh Arnold Investment Consultant, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Josh Arnold Investment Consultant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Josh Arnold Investment Consultant, LLC with notifications on news.